US FDA approves Lilly's Mounjaro to reduce cardiovascular risk
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
🌍 Cross-language spread
This story first appeared in 🇪🇸 Spanish coverage — 4.7 hours before PULSE detected it in English news.
Detected by matching proper nouns and figures that survive translation. Times reflect when each edition's coverage was first indexed.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"US FDA approves Lilly's Mounjaro to reduce cardiovascular risk" is generating significant coverage in the Business category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Bloomberg.com, Harvard Health, Fierce Pharma and Eli Lilly and Company. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 10h ago.
Quick answers
Why is "US FDA approves Lilly's Mounjaro to reduce cardiovascular risk" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (9)
- Mounjaro Is Now Approved to Lower the Risk of Heart Events Time Magazine · 7h ago
- Eli Lilly's diabetes drug Mounjaro gets approval for a new use USA Today · 7h ago
- Eli Lilly's diabetes drug wins FDA approval to lower heart attack and stroke risk qz.com · 14h ago
- Tirzepatide Gets FDA Approval to Cut Cardiovascular Risk in Type 2 Diabetes HCPLive · 14h ago
- Lilly Diabetes Shot Mounjaro Wins US Approval for Heart Disease Bloomberg.com · 14h ago
- Weight-loss drug may lower risk of heart attacks and infections Harvard Health · 14h ago
- Lilly scores Novo-pressuring Mounjaro expansion to curb heart risks in diabetes patients Fierce Pharma · 14h ago
- FDA approves Lilly's Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetes Eli Lilly and Company · 14h ago
- US FDA approves Lilly's Mounjaro to reduce cardiovascular risk Reuters · 14h ago
Topics
Related trends
FDA Authorizes Juul to Sell New E-Cigarette
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
FDA just approved updated covid shots. Here’s what to know as cases edge upward.
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
What to Know About New Covid Vaccines for Fall 2026
FDA clears new Moderna and XFG‑Adapted COVID shots for fall 2026 as cases climb, prompting fresh media focus on seasonal protection.
FDA approves daily HIV pill from Gilead designed to simplify treatment for some patients
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
FDA approves landmark pancreatic cancer drug that’s shown to improve survival
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
FDA Approves Drug for Pancreatic Cancer in Milestone for Treatment of Deadly Disease
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.